Skip to content
★ Sign in to follow
UH

Uli Hacksell

InDex Pharmaceuticals Holding AB
Total declarations
5
Company
1
▲ Purchases (3 ops.)
€40k
▼ Sales (0 ops.)
—

Latest filing published 10 Feb 2021 for InDex Pharmaceuticals Holding AB, €40k.

Filing timeline

BuySale
Uli Hacksell

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Uli Hacksell: trading record in brief

Uli Hacksell is a declared insider of InDex Pharmaceuticals Holding AB, with filings sourced from Finansinspektionen. In total, 5 filings cover trades dated from 15 June 2018 to 9 February 2021.

Purchases make up the whole of the open-market record (3 purchases, €40k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €10k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 10 February 2021 with a transaction (€40k) in InDex Pharmaceuticals Holding AB. The latest purchase dates back some time: it was published 2,585 days ago, on 10 October 2019. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Uli Hacksell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ●
    StyrelseledamotExecutivesInDex Pharmaceuticals Holding AB
    408,000 SEK0FI-SE
    340,000 shares@ SEK 1.2050.5% of flowBTA (betald tecknad aktie)ISIN SE0015503388FI:csv-b28801875b20d89d2c56
  • ●
    StyrelseledamotExecutivesInDex Pharmaceuticals Holding AB
    0FI-SE
    340,000 shares0Teckningsrätt/UniträttISIN SE0015503370FI:csv-96438052aff074485bcb
  • ▲
    Styrelseledamot/suppleantExecutivesInDex Pharmaceuticals Holding AB
    318,500 SEK32FI-SE
    50,000 shares@ SEK 6.3773.7% of flowAktieISIN SE0008966295FI:csv-8360afce56f9f97eeb6f
    Canonical exit: 7 Jan 2020 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutivesInDex Pharmaceuticals Holding AB
    105,048 SEK25FI-SE
    15,000 shares@ SEK 7.003226.3% of flowISIN SE0008966295FI:csv-5721e7607688904202cc
    Canonical exit: 13 Sept 2018 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutivesInDex Pharmaceuticals Holding AB
    105 SEK22FI-SE
    15 shares@ SEK 7.00330.0% of flowISIN SE0008966295FI:csv-d05e1697f139928d7b21
    Canonical exit: 13 Sept 2018 (T+90)

5 of 5 declarations